NMNeil McMillan

Neil McMillan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Neil McMillan has a total of 112 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher B. Sturdy

    Department of Psychology, University of Alberta, Edmonton, AB, Canada

    16 shared publications
  • Allison H. Hahn

    Department of Psychology, University of Alberta, P217 Biological Sciences Building, Edmonton, AB, T6G 2E9, Canada

    9 shared publications
  • Jenna V. Congdon

    Department of Psychology, Faculty of Health, York University, Toronto, ON M3J 1P3, Canada

    8 shared publications
  • Marcia L. Spetch

    Department of Psychology, University of Alberta

    7 shared publications
  • William A. Roberts

    Department of Psychology Department of Psychology Department of Psychology Department of Psychology and Neuroscience and Mental Health Department of Psychology Department of Psychology University of Alberta University of Western Ontario University of Alberta Institute University of Alberta University of Western Ontario Uni- versity of Alberta 11455 Saskatchewan Drive Al- berta T6G 2E9 Edmonton Canada

    7 shared publications
  • Kimberley A. Campbell

    Department of Psychology, University of Alberta, P217 Biological Sciences Building, Edmonton, AB, T6G 2E9, Canada

    6 shared publications

Latest Publications

  • Open Access

    Autophagic flux is increased in peripheral blood mononuclear cells in atherosclerotic vascular disease and associates inversely with adverse cardiovascular events

    by Bronwyn Beelders, Leanne K. Hein, Naomi Wattchow, Mau T. Nguyen, Shabnam Torabiardakani, Thalia Salagaras, Sanuri Liyanage, Christina A. Bursill, Robert Fitridge, Neil McMillan, et al.

    Background: Autophagy is a homeostatic pathway supporting stress adaptation and is dysregulated in atherosclerosis. Its potential as a biomarker or therapeutic target in atherosclerotic vascular disease (ASVD) remains incompletely defined. We measured autophagic flux in peripheral blood mononuclear cells (PBMCs) from patients with peripheral arterial disease (PAD) or carotid stenosis (CS), compared with healthy controls, and explored clinical outcome associations. Methods: Ninety-four patients with PAD or CS and 19 healthy controls were studied. Autophagic flux was quantified from fresh blood using a validated ex vivo chloroquine-inhibition ELISA measuring LC3B-II accumulation. Major adverse cardiovascular events (MACE) and major adverse limb events (MALE) were ascertained over a median follow-up of 828 days. Results: The ASVD cohort comprised claudication (n = 16), chronic limb-threatening ischemia (CLTI; n = 49), and CS (n = 29). Autophagic flux was higher in ASVD than controls (mean 281.4 vs. 182.3 ng LC3B-II/mg protein/h; p < 0.0001) and remained independently associated after multivariable adjustment. Within CLTI, concurrent infection was associated with lower flux (p = 0.001), approaching control levels (p = 0.327). In CLTI, higher flux quartiles were associated with lower MACE risk, most strongly for quartile 3 (hazard ratio 0.07 vs. quartile 1, 95% CI 0.01–0.50; p = 0.009). Conclusion: Autophagic flux is elevated in PBMCs from ASVD patients, independent of age and sex. Attenuated flux in CLTI with concurrent infection may indicate autophagic exhaustion in advanced disease. The association between higher flux and lower MACE in CLTI suggests prognostic utility, warranting evaluation in larger prospective studies.

  • Open Access

    Acceptability and Utility of a Virtual Reality Diabetes‐Related Foot Disease Training Program for First Nations People: A Pragmatic Quasi‐Experimental Case Series Study

    by Neil McMillan, Ancret Szpak, Zygmunt Szpak, Hannah Snelling, Joseph Agius, Cathy Loughry, Kristin Graham, Sara Jones, Tinarra Ataata, Kim Morey, et al.

    Objective: To test the utility and acceptability of a novel VR training tool for community health practitioners in assessing diabetes‐related foot disease in Aboriginal and Torres Strait Islander people. Methods: The VR program featured five virtual patient models and a range of interactive assessments covering essential clinical and triage skills. Design: Pragmatic quasi‐experimental case series. Setting: The VR training program was completed in collaboration with three Aboriginal Community‐Controlled Health Organisations in regional South Australia, with recruitment directed internally at each organisation. Participants: Forty‐one primary healthcare staff participated, of which 34 were matched on pre‐ and post‐VR surveys and 20 completed at least three training scenarios. Main Outcome Measures: Evaluation consisted of pre‐test self‐efficacy scores immediately prior to participants undergoing training, submission of post‐test self‐efficacy scores, the System Usability Scale, and Training Evaluation Inventory scores after completing all training modules. Results: Following completion of VR training, participants reported increased self‐efficacy scores ( n = 20) for performing key assessment and triage skills. User feedback ( n = 39) demonstrated that participants generally agreed that the training user experience was engaging, acceptable, and of value for clinical education. Conclusion: Community health practitioners generally found the VR training tool acceptable, useful, and increased their self‐confidence in assessing and managing diabetes‐related foot disease for Aboriginal and Torres Strait Islander people, highlighting the potential of VR to upskill community practitioners.

  • Open Access

    Plasma-Activated Water: A Dual-Action Disinfectant and Wound Healing Therapy for Diabetes-Related Foot Infections

    by Angela Boahen, Adrian I. Abdo, Neil McMillan, Guilherme Pena, Katharina Richter

    Globally, approximately 18.6 million individuals develop diabetic foot ulcers each year, with an estimated 50–60% of these cases subsequently becoming infected. Diabetes-related foot infections (DFI) are a common and serious complication for patients with diabetes, often resulting in gangrene, lower extremity amputation and eventually death. Multidrug resistance among DFI pathogens aggravates treatment failure, driving up healthcare costs and morbidity. Addressing this multifaceted challenge necessitates the development of novel, synergistic, and innovative therapeutic strategies. Plasma-activated water (PAW) is an emerging solution, produced by treating water with cold plasma; an ionized gas that generates a complex mixture of reactive oxygen and nitrogen species. PAW elicits potent broad-spectrum antimicrobial and antibiofilm activity against a wide range of pathogens implicated in chronic wound infections, including DFI. Moreover, PAW has been shown to accelerate wound healing through modulating immune cell activity and promoting epithelial cell proliferation and migration into wounds. In this review, we summarize: (i) the prevalence and recurrence of DFIs, (ii) methods for PAW generation and its physicochemical properties, (iii) the antimicrobial and antibiofilm efficacy of PAW against clinically relevant DFI pathogens, (iv) its effects on cellular behavior, including immune modulation and promotion of epithelial regeneration, (v) PAW as a stand-alone or synergistic therapy (vi) current limitations in PAW application, including standardization, delivery, and regulatory hurdles. Together, this rationale highlights the notion that PAW holds significant potential as a next-generation therapeutic approach for DFIs and other chronic wounds.

  • Open Access

    The Australia and N ew Z ealand Diabetic and Ischaemic Foot Outcomes Study ( ANZDIFOS )

    by Odette Hart, Philip Allan, Shirley Jansen, Robert Fitridge, Claire Murray, Mendel Baba, Prue Cowled, Neil McMillan, Manar Khashram

    Objective: There is limited high‐quality data on the factors that contribute to limb loss in patients with diabetes‐related foot disease (DFD) in New Zealand and Australia. Furthermore, wound, ischaemia and foot infection (WIfI) staging has not been validated in the Australasian cohort. The aim of this study was to (1) report on the presentation, management and outcomes of DFD (wound healing, major limb amputation [MLA], amputation‐free survival [AFS] and mortality at 1‐year), and (2) validate the association of WIfI stage on outcomes. Methods: This was an observational prospective study of patients with DFD and a wound at three centres in New Zealand and Australia from 2020 to 2022. Data on presentation, management, amputation and mortality at 1‐year was collected. Outcomes were stratified by presenting WIfI stage. Wound healing and survival were assessed with Kaplan–Meier curves, time‐to‐healing with Fine‐Gray competing risks, AFS with logistic regression and survival with Cox proportional hazards. Results: Two hundred and seventy‐six patients (384 limbs) were recruited, with WIfI stage 1 (47.9%), 2 (21.1%), 3 (19.5%) and 4 (12.5%). At 1‐year, 71.4% of wounds healed, with WIfI stage associated with healing, p < 0.001. At 1‐year 16.6% of limbs had underwent a MLA, with the proportion increasing by WIfI stage. Poorer AFS was observed with increasing WIfI. Mortality at 1‐year increased with WIfI stage, p < 0.001. Conclusion: This study reports on the presentation, management and outcomes from DFD in New Zealand and Australia. WIfI staging appropriately classifies patients with DFD and correlates with healing, MLA, AFS and survival at 1‐year.

  • Open Access

    Development of 3D printed microchips with encapsulated channels as miniaturized separation devices for bioanalysis

    by Christopher T. Desire, R. Dario Arrua, Billy Michalatos, Jing Zhang, Xanthe L. Venn, Michael Breadmore, Zlatko Kopecki, Neil McMillan, Robert Fitridge, Emily F. Hilder, et al.


  • William Roberts

    by Neil McMillan

  • Open Access

    The shifting care and outcomes for patients with endangered limbs – Critical limb ischemia (SCOPE-CLI) registry overview of study design and rationale

    by Lindsey E. Scierka, Carlos Mena-Hurtado, Mehdi H. Shishehbor, John A. Spertus, Sameer Nagpal, Trissa Babrowski, Matthew C. Bunte, Amani Politano, Misty Humphries, Jayer Chung, et al.


  • Living near the edge: How extreme outcomes and their neighbors drive risky choice.

    by Elliot A. Ludvig, Christopher R. Madan, Neil McMillan, Yaqian Xu, Marcia L. Spetch

    Extreme stimuli are often more salient in perception and memory than moderate stimuli. In risky choice, when people learn the odds and outcomes from experience, the extreme outcomes (best and worst) also stand out. This additional salience leads to more risk-seeking for relative gains than for relative losses-the opposite of what people do when queried in terms of explicit probabilities. Previous research has suggested that this pattern arises because the most extreme experienced outcomes are more prominent in memory. An important open question, however, is what makes these extreme outcomes more prominent? Here we assess whether extreme outcomes stand out because they fall at the edges of the experienced outcome distributions or because they are distinct from other outcomes. Across four experiments, proximity to the edge determined what was treated as extreme: Outcomes at or near the edge of the outcome distribution were both better remembered and more heavily weighted in choice. This prominence did not depend on two metrics of distinctiveness: lower frequency or distance from other outcomes. This finding adds to evidence from other domains that the values at the edges of a distribution have a special role. (PsycINFO Database Record (c) 2018 APA, all rights reserved).


  • Cue integration in spatial search for jointly learned landmarks but not for separately learned landmarks.

    by Yu Du, Neil McMillan, Christopher R. Madan, Marcia L. Spetch, Weimin Mou

    The authors investigated how humans use multiple landmarks to locate a goal. Participants searched for a hidden goal location along a line between 2 distinct landmarks on a computer screen. On baseline trials, the location of the landmarks and goal varied, but the distance between each of the landmarks and the goal was held constant, with 1 landmark always closer to the goal. In Experiment 1, some baseline trials provided both landmarks, and some provided only 1 landmark. On probe trials, both landmarks were shifted apart relative to the previously learned goal location. Participants searched between the locations specified by the 2 landmarks and their search locations were shifted more toward the nearer landmark, suggesting a weighted integration of the conflicting landmarks. Moreover, the observed variance in search responses when both cues were presented in their normal locations was reduced compared to the variance on tests with single landmarks. However, the variance reduction and the weightings of the landmarks did not always show Bayesian optimality. In Experiment 2, some participants were trained only with each of the single landmarks. On subsequent tests with the 2 cues in conflict, searching did not shift toward the nearer landmark and the variance of search responses of these single-cue trained participants was larger than their variance on single-landmark tests, and even larger than the variance predicted by using the 2 landmarks alternatively on different trials. Taken together, these results indicate that cue combination occurs only when the landmarks are presented together during the initial learning experience. (PsycINFO Database Record